These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 10331566)
1. DNA-mediated immunization of mice with plasmid encoding HBs antigen. Yoon SJ; Park JW; Ahn SY; Choe BK; Suh MH J Korean Med Sci; 1999 Apr; 14(2):187-92. PubMed ID: 10331566 [TBL] [Abstract][Full Text] [Related]
2. Effect of plasmid DNA on immunogenicity of HBsAg-anti-HBs complex. Qu D; Yuan ZH; He LF; Yang L; Li GD; Wen YM Viral Immunol; 1998; 11(2):65-72. PubMed ID: 9765028 [TBL] [Abstract][Full Text] [Related]
3. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. Chow YH; Huang WL; Chi WK; Chu YD; Tao MH J Virol; 1997 Jan; 71(1):169-78. PubMed ID: 8985336 [TBL] [Abstract][Full Text] [Related]
4. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine. Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297 [TBL] [Abstract][Full Text] [Related]
5. [Reciprocal priming-boosting role of HBsAg and DNA vaccines]. Zhou Z; Chen WS; Zhang HH; Yao JL Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517 [TBL] [Abstract][Full Text] [Related]
6. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant. Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475 [TBL] [Abstract][Full Text] [Related]
7. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection. Du DW; Jia ZS; Li GY; Zhou YY World J Gastroenterol; 2003 Jan; 9(1):108-11. PubMed ID: 12508362 [TBL] [Abstract][Full Text] [Related]
8. Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B. Dutta T; Garg M; Jain NK Vaccine; 2008 Jun; 26(27-28):3389-94. PubMed ID: 18511160 [TBL] [Abstract][Full Text] [Related]
9. [Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg]. Du X; Wang J; Kang Y; Xiao W; Zhao G; Wang B Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):938-42. PubMed ID: 19873759 [TBL] [Abstract][Full Text] [Related]
10. Localization of CD8+ cells specific for hepatitis B virus surface protein in the liver of immunized mice. Qu D; Lanier G; Yuan ZH; Wen YM; Howard CR; Ahmed R J Med Virol; 2008 Feb; 80(2):225-32. PubMed ID: 18098130 [TBL] [Abstract][Full Text] [Related]
11. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine. Zhou C; Peng G; Jin X; Tang J; Chen Z Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873 [TBL] [Abstract][Full Text] [Related]
12. Intracellular retention of hepatitis B virus surface proteins reduces interleukin-2 augmentation after genetic immunizations. Geissler M; Bruss V; Michalak S; Hockenjos B; Ortmann D; Offensperger WB; Wands JR; Blum HE J Virol; 1999 May; 73(5):4284-92. PubMed ID: 10196326 [TBL] [Abstract][Full Text] [Related]
13. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. McCluskie MJ; Brazolot Millan CL; Gramzinski RA; Robinson HL; Santoro JC; Fuller JT; Widera G; Haynes JR; Purcell RH; Davis HL Mol Med; 1999 May; 5(5):287-300. PubMed ID: 10390545 [TBL] [Abstract][Full Text] [Related]
14. Comparing the immunogenicity of hepatitis B virus S gene variants by DNA immunization. Wu L; Yuan ZH; Liu F; Waters JA; Wen YM Viral Immunol; 2001; 14(4):359-67. PubMed ID: 11792065 [TBL] [Abstract][Full Text] [Related]
15. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice]. Li L; Tian YJ; Shen H; Zhao XP; Yang DL Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026 [TBL] [Abstract][Full Text] [Related]
16. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma. Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872 [TBL] [Abstract][Full Text] [Related]
17. Vaccination with a DNA vaccine encoding CD317-targeting HBs antigen elicits enhanced immunity in mice. Zhang G; Li X; Liu L; Li J; Chen Q; Huang S; Li Y; Wan X Biochem Biophys Res Commun; 2018 Oct; 504(4):865-870. PubMed ID: 30219230 [TBL] [Abstract][Full Text] [Related]
18. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen. Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161 [TBL] [Abstract][Full Text] [Related]
19. Plasmids enriched with CpG motifs activate human peripheral blood mononuclear cells in vitro and enhance th-1 immune responses to hepatitis B surface antigen in mice. Chen Z; Cao J; Liao X; Ke J; Zhu S; Zhao P; Qi Z Viral Immunol; 2011 Jun; 24(3):199-209. PubMed ID: 21668361 [TBL] [Abstract][Full Text] [Related]
20. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice. Oka Y; Akbar SM; Horiike N; Joko K; Onji M Immunology; 2001 May; 103(1):90-7. PubMed ID: 11380696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]